(Reuters) – Generic drugmaker Teva Pharmaceutical Industries Ltd. on Tuesday proposed buying smaller rival Mylan for $40 billion, saying it was a better deal than Mylan’s alternate offer to buy Perrigo Co. The offer comes after weeks of speculation that Teva, the world’s largest generic company, would make a bid for Mylan. Teva said the […]

U.K.-based GlaxoSmithKline (GSK) announced on April 14, 2015 that it was recalling all remaining lots of its 2014-2015 Flulaval Quadrivalent flu vaccine. The company noted that two of the components of the vaccine, the B strains, appeared to have lost potency below the minimum specifications. The potency issue, according to the company, the U.S. Centers […]

RALEIGH, N.C.–(BUSINESS WIRE)–Merz Neurosciences, a division of Merz North America (U.S. affiliate of the global Merz Pharma Group), announces that it will present top-line data from its Phase 3 PURE: Post-stroke Spasticity UppeR Limb Study to Investigate Efficacy and Safety of NT 201 clinical trial for incobotulinumtoxinA during the 67th Annual Meeting of the American […]

Swiss drugmaker Roche (RHHBY) is doubling down on its immunotherapy oncology pipeline, on Monday announcing it will pay Indian company Curadev Pharma up to $555 million to develop and market its IDO1 and TDO inhibitors IDO1 (indoleamine-2, 3-dioxygenase-1) and TDO (tryptophan-2, 3-dioxygenase) are enzymes that mediate cancer-induced immune suppression, which tumor cells and a certain […]

Generic drugmaker Mylan wants to put speculation of a possible merger with Teva Pharmaceuticals to rest. A potential deal, the company said, is “without sound industrial logic” and would have a hard time winning anti-trust clearances. Mylan’s comments on Friday responded to reports from both Bloomberg and the Wall Street Journal that indicated Teva Pharmaceutical is considering […]

TOKYO – Daiichi Sankyo Company is divesting itself of 8.9 percent stake in Sun Pharma, India’s largest drugmaker, on the Indian stock exchange, the company announced Monday morning. The company said it is selling the Sun Pharma shares, which were acquired following the completion of Sun Pharma’s merger with Ranbaxy Laboratories Limited last month, from the […]

When an international corporation comes into a region, or leaves that region, its impact has a ripple effect on the local economy in numerous ways. In light of recent job cuts by GlaxoSmithKline (GSK) in Research Triangle Park, N.C., the effects on the local airline industry are being examined. In 1994, American Airlines debuted a […]

Rumors that Teva Pharmaceutical Industries Ltd. (TEVA) and Mylan Inc. (MYL) are finally ready to merge have once again been roiling the market, after people familiar with the matter told Bloomberg News they expect a formal bid from Teva for Mylan soon, in a move that will make one of the world’s largest global generic-drug […]

(Reuters) – Teva Pharmaceutical Industries shares slid five percent on Sunday after U.S. regulators approved a generic version of its top-selling multiple sclerosis drug and amid reports it was mulling a bid for rival Mylan. Teva’s Tel Aviv shares fell to 249.80 shekels ($64) late on Sunday, the first day of trading since both news […]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapeutics for cancer patients, today announced that the underwriters for its recently completed underwritten public offering of common stock have partially exercised their option to purchase additional shares of common stock from Epizyme. The underwriters purchased 701,448 shares from Epizyme at […]